PrEP Knowledge, Attitudes, and Use Intentions Among Black College Students in the South

Friday, June 11th 2021

11:30 AM - 1:00 PM

Register Now

Black youth and young adults in the South are disproportionately affected by HIV. Pre-exposure prophylaxis (PrEP) is an effective HIV prevention tool, however, there has been low uptake among Black youth. We examined PrEP knowledge, attitudes about PrEP as a prevention strategy, and intention to use PrEP among Black college students in the South and whether they differed by gender. In this study, Black college students were recruited from five universities in the South to complete an online survey on PrEP (n=269). Most of the study participants had never heard of PrEP (62%), 58% thought PrEP was a good prevention strategy, and 54% said they would use PrEP if available. However, there was no difference in gender. Lastly, those that had a higher intention of using protective behaviors had more positive attitudes towards PrEP and stated that they were more likely to use PrEP. With the lack of knowledge of PrEP on college campuses and elevated sexual risk behaviors, PrEP provides an opportunity for its incorporation in sexual health education. Additionally, there is a need for advocacy in the inclusion of women in PrEP clinical trials and usage.


  1. Provide an overview of HIV in the South among Black youth
  2. Provide an understanding of the disparities in PrEP usage among Black youth
  3. Discuss research findings
  4. Discuss next steps to ensuring PrEP is provided to the most vulnerable population


Samuella Ware, CHES

Drexel University

Dr. Samuella Ware as Postdoctoral Researcher at Drexel University’s College of Nursing and Health Professions. Her research is focused on race-based theories and social-structural factors that impact sexual health and HIV vulnerability among Black men and women.


Location Details


Spotlight On

Karam Mounzer, MD

Dr. Mounzer identified two major gaps in the care of patients with HIV/hepatitis C (HCV) co-infection, and the complexity of multidrug-resistant HIV treatment. He is involved with many clinical trials focusing on drug development and better understanding of HIV immunopathogenesis with the Wistar Institute. He is involved in teaching and mentoring.

Learn More about Spotlight On
Dr. Karam Mounzer

Dr. Mario Cruz

Dr. Mario CruzDr. Cruz is a board certified pediatrician who serves as the Medical Director for our Pediatrics and Adolescent Health Center. He has presented and/or published in the fields of community violence and domestic violence prevention, quality improvement, behavioral health, curriculum development and mentorship. In 2019 he received the Greater Philadelphia Social Innovation Award for Innovations in Healthcare.

Translate ยป